MORGAN STANLEY PLC/CALL/NOVARTIS N/107.5/0.1/20.12.24 Share Price

Warrant

DE000ME1WHV2

Real-time Bid/Ask 08:53:06 02/07/2024 pm IST
0.126 EUR / 0.138 EUR +4.76% Intraday chart for MORGAN STANLEY PLC/CALL/NOVARTIS N/107.5/0.1/20.12.24
Current month+2.44%
1 month+31.25%
Date Price Change
02/24/02 0.121 -3.97%
01/24/01 0.126 +2.44%
28/24/28 0.123 -3.91%
27/24/27 0.128 -7.91%
26/24/26 0.139 +5.30%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 06:21 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Morgan Stanley
WKN ME1WHV
ISINDE000ME1WHV2
Date issued 11/10/2023
Strike 107.5 CHF
Maturity 20/12/2024 (171 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.231
Lowest since issue 0.05
Delta0.21x
Omega 15.78
Premium13.06x
Gearing76.21x
Moneyness 0.8949
Difference Strike 11.08 CHF
Difference Strike %+10.30%
Spread 0.01
Spread %7.41%
Theoretical value 0.1300
Implied Volatility 17.39 %
Total Loss Probability 82.55 %
Intrinsic value 0.000000
Present value 0.1300
Break even 108.76 €
Theta-0.01x
Vega0.02x
Rho0.01x

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107 USD
Average target price
110.3 USD
Spread / Average Target
+3.05%
Consensus